BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15074605)

  • 1. Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors.
    Gao JQ; Alexandre LS; Tsuda Y; Katayama K; Eto Y; Sekiguchi F; Mizuguchi H; Hayakawa T; Nakayama T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Pharmazie; 2004 Mar; 59(3):238-9. PubMed ID: 15074605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
    Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy.
    Okada N; Gao JQ; Sasaki A; Niwa M; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Fujita T; Yamamoto A; Tsutsumi Y; Mayumi T; Nakagawa S
    Biochem Biophys Res Commun; 2004 Apr; 317(1):68-76. PubMed ID: 15047149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
    Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene.
    Tsuda H; Wada T; Yamashita T; Hamada H
    J Gene Med; 2005 Oct; 7(10):1322-34. PubMed ID: 15926193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.
    Gao JQ; Sugita T; Kanagawa N; Iida K; Okada N; Mizuguchi H; Nakayama T; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Biol Pharm Bull; 2005 Jun; 28(6):1066-70. PubMed ID: 15930746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses.
    Schmitz M; Graf C; Gut T; Sirena D; Peter I; Dummer R; Greber UF; Hemmi S
    Gene Ther; 2006 Jun; 13(11):893-905. PubMed ID: 16482201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
    Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
    Rittner K; Schreiber V; Erbs P; Lusky M
    Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of proinsulin 1 or 2-expressing fiber-mutant recombinant adenovirus vector protects against the development of diabetes in NOD mice.
    Yamada K; Moriyama H; Okumachi Y; Arai T; Kameno M; Kishi M; Yasuda H; Hara K; Yokono K; Nagata M
    Ann N Y Acad Sci; 2008 Dec; 1150():183-6. PubMed ID: 19120291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D; Meyer B; Wildner O
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
    Ni S; Gaggar A; Di Paolo N; Li ZY; Liu Y; Strauss R; Sova P; Morihara J; Feng Q; Kiviat N; Touré P; Sow PS; Lieber A
    Cancer Gene Ther; 2006 Dec; 13(12):1072-81. PubMed ID: 16874361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression.
    Liu Q; White LR; Clark SA; Heffner DJ; Winston BW; Tibbles LA; Muruve DA
    J Virol; 2005 Dec; 79(23):14507-15. PubMed ID: 16282450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
    Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
    Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene].
    Ling CQ; Li B; Zhang C; Gu W; Li SX; Huang XQ; Zhang YN
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):741-4. PubMed ID: 15619342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.